MetaDeq
PrivateCompany Overview
MetaDeq is a diagnostics company that develops non-invasive, blood-based diagnostic tests for metabolic dysfunction-associated steatohepatitis (MASH) and liver fibrosis.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Medical Devices
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
medical diagnosticsliver fibrosisMASHmetabolic dysfunction-associated steatohepatitisnon-invasive biopsyliquid biopsybiomarker diagnosticscompanion diagnosticsclinical trial screeningpredictive algorithmliver disease monitoringMASLDmetabolic dysfunction-associated steatotic liver diseaseAI diagnosticsCRO services
Historical Pricing
Historical view of private secondary pricing and transaction trends.
MetaDeq Comparables
Compare MetaDeq with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Hepta Bio | 87% | |
| Fibronostics | 86% | |
| AGED Diagnostics | 86% | |
MetaDeq Funding Rounds
Historical fundraising activity
MetaDeq Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about MetaDeq's valuation, stock price, and market status.